XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Stock option    
Share-Based Compensation    
Exercise of stock options 6,807,859 4,814,173
Weighted average exercise price of options outstanding $ 9.69 $ 9.52
Unrecognized compensation expenses related to options $ 9.0 $ 14.8
Unrecognized compensation cost which is expected to be recognized over a weighted-average period 2 years 1 month 6 days 2 years 4 months 9 days
Vaccitech plc Share Award Plan 2021    
Share-Based Compensation    
Number of unvested options canceled 57,970 0
Vaccitech plc Share Award Plan 2021 | Stock option    
Share-Based Compensation    
Options granted 1,987,289  
Weighted-average grant date per-share fair value of stock options granted $ 2.01  
Weighted average exercise price of options granted $ 2.53 $ 11.24
Vaccitech plc Share Award Plan 2021 | Restricted share units, options, share appreciation rights and restricted shares    
Share-Based Compensation    
Percentage of issued and outstanding ordinary shares available for issuance under the Plan 4.00%  
Enterprise Management Incentive Share Option Scheme | Stock option    
Share-Based Compensation    
Options granted   1,632,922
Weighted-average grant date per-share fair value of stock options granted   $ 3.75